Clinical Trial Update: A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema [Phase 2]

View source ↗

Summary

Update on the Phase 2 long-term study of STAR-0215 in participants with hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• STAR-0215

Snippet

Sponsor: Astria Therapeutics, Inc. | Conditions: Hereditary Angioedema | Phase 2 | Status: ACTIVE_NOT_RECRUITING